Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94158, USA.
Cell. 2013 Jul 18;154(2):442-51. doi: 10.1016/j.cell.2013.06.044. Epub 2013 Jul 11.
The genetic interrogation and reprogramming of cells requires methods for robust and precise targeting of genes for expression or repression. The CRISPR-associated catalytically inactive dCas9 protein offers a general platform for RNA-guided DNA targeting. Here, we show that fusion of dCas9 to effector domains with distinct regulatory functions enables stable and efficient transcriptional repression or activation in human and yeast cells, with the site of delivery determined solely by a coexpressed short guide (sg)RNA. Coupling of dCas9 to a transcriptional repressor domain can robustly silence expression of multiple endogenous genes. RNA-seq analysis indicates that CRISPR interference (CRISPRi)-mediated transcriptional repression is highly specific. Our results establish that the CRISPR system can be used as a modular and flexible DNA-binding platform for the recruitment of proteins to a target DNA sequence, revealing the potential of CRISPRi as a general tool for the precise regulation of gene expression in eukaryotic cells.
细胞的遗传检测和重编程需要针对基因进行表达或抑制的强大而精确的靶向方法。CRISPR 相关的无催化活性的 dCas9 蛋白为 RNA 引导的 DNA 靶向提供了通用平台。在这里,我们表明,dCas9 与具有不同调控功能的效应结构域融合,可在人和酵母细胞中实现稳定且高效的转录抑制或激活,而递送部位仅由共表达的短向导(sg)RNA 决定。将 dCas9 与转录抑制结构域偶联可强力沉默多个内源性基因的表达。RNA-seq 分析表明,CRISPR 干扰(CRISPRi)介导的转录抑制具有高度特异性。我们的结果表明,CRISPR 系统可用作模块化和灵活的 DNA 结合平台,用于将蛋白质募集到靶 DNA 序列,揭示了 CRISPRi 作为真核细胞中精确调控基因表达的通用工具的潜力。